Search
29/06/2022
Atherogenicity of low-density lipoproteins after switching from a protease inhibitor to dolutegravir: a substudy of the NEAT022 study
Saumoy, M, Sanchez-Quesada, JL, Assoumou, L, Gatell, JM, Gonzalez-Cordon, A, Guaraldi, G, Domingo, P, Giacomelli, A, Connault, J, Katlama, C, Masia, M, Ordonez-Llanos, J, Pozniak, A, Martinez, E, Podzamczer, D. Atherogenicity of low-density lipoproteins after switching from a protease inhibitor to dolutegravir: a substudy of the NEAT022 study. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY. 2022; 77(7)DOI:10.1093/jac/dkac117. PMID:35411401. IF:5.200(Q1/3D).
27/06/2022
The Robustness of Cellular Immunity Determines the Fate of SARS-CoV-2 Infection
Moga, E, Lynton-Pons, E, Domingo, P. The Robustness of Cellular Immunity Determines the Fate of SARS-CoV-2 Infection. Frontiers in Immunology. 2022; 13DOI:10.3389/fimmu.2022.904686. PMID:35833134. IF:7.300(Q1/3D).
01/05/2022
Pulmonary Infections in People Living with HIV
Franquet, T, Domingo, P. Pulmonary Infections in People Living with HIV. RADIOLOGIC CLINICS OF NORTH AMERICA. 2022; 60(3)DOI:10.1016/j.rcl.2022.01.008. PMID:35534134. IF:1.900(Q3/8D).
01/03/2022
Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Versus Dolutegravir/Abacavir/Lamivudine in Antiretroviral-Naive Adults (SYMTRI): A Multicenter Randomized Open-Label Study (PReEC/RIS-57)
Podzamczer, D, Mican, R, Tiraboschi, J, Portilla, J, Domingo, P, Llibre, JM, Ribera, E, Vivancos, MJ, Morano, L, Masia, M, Gomez, C, Fanjul, F, Payeras, A, Inciarte, A, Estrada, V, Rivero, A, Castro, A, Bernal, E, Vinuesa, D, Knobel, H, Troya, J, Macias, J, Montero, M, Sanz, J, Navarro-Alcaraz, A, Caicedo, A, Fernandez, G, Martinez, E, Moreno, S. Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Versus Dolutegravir/Abacavir/Lamivudine in Antiretroviral-Naive Adults (SYMTRI): A Multicenter Randomized Open-Label Study (PReEC/RIS-57). Open Forum Infectious Diseases. 2022; 9(3)DOI:10.1093/ofid/ofab595. PMID:35237700. IF:4.200(Q2/4D).
17/02/2022
Posterior Cervical Brown Fat and CXCL14 Levels in the First Year of Life: Sex Differences and Association With Adiposity
Garcia-Beltran, C, Cereijo, R, Plou, C, Gavalda-Navarro, A, Malpique, R, Villarroya, J, Lopez-Bermejo, A, de Zegher, F, Ibanez, L, Villarroya, F. Posterior Cervical Brown Fat and CXCL14 Levels in the First Year of Life: Sex Differences and Association With Adiposity. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM. 2022; 107(3)DOI:10.1210/clinem/dgab761. PMID:34677618. IF:5.800(Q1/3D).
01/02/2022
Increased Circulating Levels of Growth Differentiation Factor 15 in Association with Metabolic Disorders in People Living with HIV Receiving Combined Antiretroviral Therapy
Domingo, P, Mateo, MG, Villarroya, J, Cereijo, R, Torres, F, Domingo, JC, Campderros, L, Gallego-Escuredo, JM, Gutierrez, MD, Mur, I, Corbacho, N, Vidal, F, Villarroya, F, Giralt, M. Increased Circulating Levels of Growth Differentiation Factor 15 in Association with Metabolic Disorders in People Living with HIV Receiving Combined Antiretroviral Therapy. Journal of Clinical Medicine. 2022; 11(3)DOI:10.3390/jcm11030549. PMID:35160008. IF:3.900(Q2/4D).
01/02/2022
Adipokines as New Biomarkers of Immune Recovery: Apelin Receptor, RBP4 and ZAG Are Related to CD4(+) T-Cell Reconstitution in PLHIV on Suppressive Antiretroviral Therapy
Yeregui, E, Masip, J, Vilades, C, Domingo, P, Pacheco, YM, Blanco, J, Mallolas, J, Alba, V, Vargas, M, Garcia-Pardo, G, Negredo, E, Olona, M, Vidal-Gonzalez, J, Peraire, M, Marti, A, Reverte, L, Gomez-Bertomeu, F, Leal, M, Vidal, F, Peraire, J, Rull, A. Adipokines as New Biomarkers of Immune Recovery: Apelin Receptor, RBP4 and ZAG Are Related to CD4(+) T-Cell Reconstitution in PLHIV on Suppressive Antiretroviral Therapy. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2022; 23(4)DOI:10.3390/ijms23042202. PMID:35216318. IF:5.600(Q1/3D).
27/01/2022
Exposure to valproic acid is associated with less pulmonary infiltrates and improvements in diverse clinical outcomes and laboratory parameters in patients hospitalized with COVID-19
Collazos, J, Domingo, P, Fernandez-Araujo, N, Asensi-Diaz, E, Vilchez-Rueda, H, Lalueza, A, Roy-Vallejo, E, Blanes, R, Raya-Cruz, M, Sanz-Canovas, J, Artero, A, Ramos-Rincon, JM, Duenas-Gutierrez, C, Lamas-Ferreiro, JL, Asensi, V. Exposure to valproic acid is associated with less pulmonary infiltrates and improvements in diverse clinical outcomes and laboratory parameters in patients hospitalized with COVID-19. PLoS One. 2022; 17(1)DOI:10.1371/journal.pone.0262777. PMID:35085321. IF:3.700(Q2/4D).